Instructing iPS cell-derived mesenchymal stem cells to inhibit abnormal bone formation in FOP
A team of researchers led by Associate Professor Makoto Ikeya (Department of Clinical Application) has observed early signs of success from providing iPSC-derived mesenchymal stem/stromal cells (iMSCs) instructions to produce ...
Mar 27, 2024
0
0